Literature DB >> 29858374

Regulation of Cytosolic Sulfotransferases in Models of Human Hepatocyte Development.

Sarah Dubaisi1, Kathleen G Barrett1, Hailin Fang1, Jorge Guzman-Lepe1, Alejandro Soto-Gutierrez1, Thomas A Kocarek1, Melissa Runge-Morris2.   

Abstract

Cytosolic sulfotransferases (SULTs) are expressed during early life and therefore metabolize endogenous and xenobiotic chemicals during development. Little is currently known about the regulation of individual SULTs in the developing human liver. We characterized SULT expression in primary cultures of human fetal hepatocytes and the HepaRG model of liver cell differentiation. SULT1A1 (transcript variants 1-4), SULT1C2, SULT1C4, SULT1E1, and SULT2A1 were the most abundant transcripts in human fetal hepatocytes. In HepaRG cells, SULT1B1, SULT1C2/3/4, and SULT1E1 mRNA levels increased during the transition from proliferation to confluency and then decreased as the cells underwent further differentiation. By contrast, SULT2A1 mRNA levels increased during differentiation, whereas SULT1A1 and SULT2B1 mRNA levels remained relatively constant. The temporal patterns of SULT1C2, SULT1E1, and SULT2A1 protein content were consistent with those observed at the mRNA level. To identify regulators of SULT expression, cultured fetal hepatocytes and HepaRG cells were treated with a panel of lipid- and xenobiotic-sensing receptor activators. The following effects were observed in both fetal hepatocytes and HepaRG cells: 1) liver X receptor activator treatment increased SULT1A1 transcript variant 5 levels; 2) vitamin D receptor activator treatment increased SULT1C2 and SULT2B1 mRNA levels; and 3) farnesoid X receptor activator treatment decreased SULT2A1 expression. Activators of aryl hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, and peroxisome proliferator-activated receptors produced additional gene-dependent effects on SULT expression in HepaRG cells. These findings suggest that SULT-regulating chemicals have the potential to modulate physiologic processes and susceptibility to xenobiotic stressors in the developing human liver.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29858374      PMCID: PMC6038032          DOI: 10.1124/dmd.118.081398

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  59 in total

1.  Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver.

Authors:  Zhengbo Duanmu; Amy Weckle; Sevasti B Koukouritaki; Ronald N Hines; Josie L Falany; Charles N Falany; Thomas A Kocarek; Melissa Runge-Morris
Journal:  J Pharmacol Exp Ther       Date:  2005-12-09       Impact factor: 4.030

2.  Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1α binding to HNF4α.

Authors:  Shuai Wang; Xue Yuan; Danyi Lu; Lianxia Guo; Baojian Wu
Journal:  Biochem Pharmacol       Date:  2017-09-11       Impact factor: 5.858

3.  Dehydroepiandrosterone sulfotransferase in the developing human fetus: quantitative biochemical and immunological characterization of the hepatic, renal, and adrenal enzymes.

Authors:  E V Barker; R Hume; A Hallas; W H Coughtrie
Journal:  Endocrinology       Date:  1994-02       Impact factor: 4.736

4.  Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor.

Authors:  Hai-Lin Fang; Stephen C Strom; Hongbo Cai; Charles N Falany; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Mol Pharmacol       Date:  2005-01-05       Impact factor: 4.436

5.  Expression, purification and characterization of human cytosolic sulfotransferase (SULT) 1C4.

Authors:  Amber L Guidry; Zachary E Tibbs; Melissa Runge-Morris; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2017-01-01

6.  Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues.

Authors:  U Berger; P Wilson; R A McClelland; K Colston; M R Haussler; J W Pike; R C Coombes
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

7.  Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate.

Authors:  Katia Sayyed; Marc Le Vee; Ziad Abdel-Razzak; Elodie Jouan; Bruno Stieger; Claire Denizot; Yannick Parmentier; Olivier Fardel
Journal:  Toxicology       Date:  2016-07-19       Impact factor: 4.221

8.  The histone deacetylase inhibiting drug Entinostat induces lipid accumulation in differentiated HepaRG cells.

Authors:  Abigail D G Nunn; Tullio Scopigno; Natalia Pediconi; Massimo Levrero; Henning Hagman; Juris Kiskis; Annika Enejder
Journal:  Sci Rep       Date:  2016-06-20       Impact factor: 4.379

9.  Gene expression data from acetaminophen-induced toxicity in human hepatic in vitro systems and clinical liver samples.

Authors:  Robim M Rodrigues; Olivier Govaere; Tania Roskams; Tamara Vanhaecke; Vera Rogiers; Joery De Kock
Journal:  Data Brief       Date:  2016-03-26

10.  Structural and chemical profiling of the human cytosolic sulfotransferases.

Authors:  Abdellah Allali-Hassani; Patricia W Pan; Ludmila Dombrovski; Rafael Najmanovich; Wolfram Tempel; Aiping Dong; Peter Loppnau; Fernando Martin; Janet Thornton; Janet Thonton; Aled M Edwards; Alexey Bochkarev; Alexander N Plotnikov; Masoud Vedadi; Cheryl H Arrowsmith
Journal:  PLoS Biol       Date:  2007-05       Impact factor: 8.029

View more
  6 in total

1.  Developmental Expression of SULT1C4 Transcript Variants in Human Liver: Implications for Discordance Between SULT1C4 mRNA and Protein Levels.

Authors:  Sarah Dubaisi; Hailin Fang; Joseph A Caruso; Roger Gaedigk; Carrie A Vyhlidal; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2020-04-17       Impact factor: 3.922

2.  Aha1 Is an Autonomous Chaperone for SULT1A1.

Authors:  Xiaochuan Liu; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2022-08-04       Impact factor: 3.973

Review 3.  Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.

Authors:  Ankit Balhara; Aditya R Kumar; Jashvant D Unadkat
Journal:  J Clin Pharmacol       Date:  2022-09       Impact factor: 2.860

4.  RORα phosphorylation by casein kinase 1α as glucose signal to regulate estrogen sulfation in human liver cells.

Authors:  Hao Hu; Masahiko Negishi
Journal:  Biochem J       Date:  2020-09-30       Impact factor: 3.857

5.  CYP46A1-dependent and independent effects of efavirenz treatment.

Authors:  Natalia Mast; Nicole El-Darzi; Alexey M Petrov; Young Li; Irina A Pikuleva
Journal:  Brain Commun       Date:  2020-10-29

6.  Ontogeny of Hepatic Sulfotransferases and Prediction of Age-Dependent Fractional Contribution of Sulfation in Acetaminophen Metabolism.

Authors:  Mayur K Ladumor; Deepak Kumar Bhatt; Andrea Gaedigk; Sheena Sharma; Aarzoo Thakur; Robin E Pearce; J Steven Leeder; Michael B Bolger; Saranjit Singh; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2019-05-17       Impact factor: 3.922

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.